Diagnostic Imaging Market Report Scope & Overview:

The global diagnostic imaging market size was valued at USD 48.97 billion in 2025E and is projected to reach USD 68.11 billion by 2033, growing at a CAGR of 4.23% during the forecast period 2026–2033.

The worldwide diagnostic imaging market is expanding steadily, with over 4.5 billion imaging procedures performed annually by 2025. Contributing more than 55% of the global usage, X-ray and ultrasound claim a fair share owing to cost-efficacy and availability, however MRI and CT continue to witness robust adoption in advanced diagnostics. In particular, portable systems and also hand-held systems are becoming attractive especially in developing countries. Digital enhancements, AI and hybrid imaging solutions are driving worldwide acceptance in healthcare organizations.

X-ray and ultrasound systems together comprised over 55% of diagnostic imaging demand in 2025.

Market Size and Forecast:

  • Market Size in 2025: USD 48.97 Billion

  • Market Size by 2033: USD 68.11 Billion

  • CAGR: 4.23% from 2026 to 2033

  • Base Year: 2025

  • Forecast Period: 2026–2033

  • Historical Data: 2022–2024

Diagnostic Imaging Market Trends:

  • Fusion imaging using PET-CT and PET-MRI will be performed in greater than 15% of nuclear imaging studies by 2030.

  • CT and MRI volumes will rise by almost 30% from 2025 to 2029 with advanced diagnostics tests for diseases growing.

  • North America is predicted to hold over 38% of global diagnostic imaging revenues in 2027, with the region benefiting from high reimbursement and early uptake.

  • Oncology and cardiology screening programs are expected to lead imaging demand to grow by 25% by 2028.

  • Portable and hand-held imaging to capture more than a fifth of the global market for installations by 2030 as adoption grows for point-of-care diagnostics.

U.S. Diagnostic Imaging Insights:

The U.S. dominates the North American diagnostic imaging market, valued at USD 15.64 billion in 2025E and projected to reach USD 20.60 billion by 2033, growing at a CAGR of 3.53%. With over 80 million CT and MRI scans annually and strong AI-driven adoption, the U.S. remains the hub of advanced imaging innovation.

Diagnostic Imaging Market Growth Drivers:

  • AI Integration and Digital Advancements in Imaging Systems Enhance Accuracy, Efficiency, and Global Adoption Across Healthcare Facilities.

AI and digital innovations are key market drivers for the diagnostic imaging sector. By 2025, more than 35% of new imaging systems installed worldwide will have integrated AI-based capabilities rapidly extending beyond detection into workflow efficiencies and predictive analytics. These systems can increase the diagnostic accuracy by 20%, and reduce reporting time significantly. Hospitals and imaging centers equipped with AI-based imaging will be able to improve their throughput, and as a result benefit from higher patient-level care while providers experience greater clinical productivity.

In 2025, AI-enabled imaging systems grew by nearly 15% year-on-year, making them the fastest-growing segment in diagnostic imaging.

Diagnostic Imaging Market Restraints:

  • High Equipment and Maintenance Costs Limit Accessibility of Advanced Imaging Systems in Low- and Middle-Income Regions.

Heavy equipment and high maintenance are the leading impediments in the market of diagnostic imaging. State-of-the-art MRI machines weigh upwards of 7 tons and need custom installation and climate control. Its annual service requirements mean systems can be unavailable up to 10% of the time. Less than 5 MRI scanners per million people are available in low- and middle-income countries compared with over 40 per million in high-income regions, limiting access to advanced imaging.

Diagnostic Imaging Market Opportunities:

  • Expanding Preventive Screening Programs and Early Disease Detection Initiatives Create Significant Growth Opportunities for Diagnostic Imaging Providers.

Few other prominent opportunities can also be seen for the diagnostic imaging market including growth of preventive screening programs. By 2025, nearly 50% of adults in the world will receive at least one image examination each year (mostly due to screenings). For instance, worldwide breast cancer screening programs have driven a 22% increase in mammography use since 2020 and CT lung screening has risen by 18% in high-risk populations. These initiatives highlight the increasing importance of imaging in early detection and long-term health trends.

In 2025, preventive screening accounted for nearly 48% of global diagnostic imaging procedures, creating strong opportunities for early detection services.

Diagnostic Imaging Market Segmentation Analysis:

  • By Product Type, X-ray Systems dominated the market with a share of 29.53% in 2025E, while Computed Tomography (CT) Scanners are growing at the highest CAGR of 5.96%.

  • By Application, Cardiology accounted for 58.27% in 2025E, followed by Neurology which is expected to grow at a CAGR of 6.10%.

  • By Technology, 2D Imaging led with the largest share of 52.30% in 2025E, while Fusion Imaging is projected to grow fastest at a CAGR of 7.25%.

  • By Modality, Fixed Imaging Systems dominated with a share of 81.04% in 2025E, whereas Portable Imaging Systems are set to expand at the highest CAGR of 6.52%.

  • By End User, Hospitals captured the largest share of 56.75% in 2025E, while Diagnostic Imaging Centers are projected to grow at a CAGR of 7.10%.

  • By Distribution Channel, Direct Sales accounted for 48.60% in 2025E, followed by Online Retail which is expected to grow rapidly at a CAGR of 12.34%.

By Product Type, X-ray Systems Dominate While CT Scanners Grow Rapidly:

X-ray remains the most widely used imaging method, with over 3.6 billion procedures performed annually worldwide by 2025. Substitution rate, speed, and indispensable necessity in critical context of emergency and routine care guarantee the supremacy. In the meantime, CT volumes are growing rapidly, increasing 18% worldwide between 2020 and 2025. Fueling growth is oncology and cardiovascular diagnostics, in which advanced CT technology offers detailed 3D imaging for early detection of disease.

By Application, Oncology Leads While Neurology Expands Fastest:

Cancer screening and management drive diagnostic imaging, with over 19 million new cancer cases worldwide in 2025 requiring regular imaging for detection, staging, and monitoring. Oncology applications are driven by mammography, CT and PET scans, and are some of the tallest piles in healthcare. But neurology is seeing an increased interest due to increasing burden of Alzheimer’s and stroke which affect over 400 million people worldwide. MRI, especially when it comes to brain and spinal diagnostics, is evolving as the frontrunner modality.

By Technology, 2D Imaging Dominates While Fusion Imaging Surges:

Conventional 2D imaging continues to dominate as the backbone of diagnostic workflows, representing the foundation of X-ray, ultrasound, and CT usage worldwide. Billions of 2D scans are performed on an annual basis because the method is reliable and available across many developed and developing world settings. Fusion imaging, however is advancing at a rapid pace, and the use of PET-CT and PET-MRI for applications outside of oncology such as cardiology and neurology are growing. Fusion techniques should represent more than 15% of nuclear imaging volumes by 2030.

By Modality, Fixed Imaging Systems Lead While Portable Imaging Gains Traction:

Fixed imaging systems dominate due to established infrastructure in hospitals and diagnostic centers, with large-scale installations supporting millions of CT, MRI, and X-ray scans annually. But there is strong adoption of mobile imaging systems. There were more than 450,000 units of POCUS sold worldwide in 2025 due to point-of-care diagnosis, emergency medicine and rural healthcare. Such instruments are becoming more and more important in underprivileged and isolated areas because of being portable, flexible and capable to provide a quick diagnosis.

By End User, Hospitals Dominate While Diagnostic Imaging Centers Expand:

Hospitals remain the primary users of diagnostic imaging, conducting over 60% of global imaging procedures by 2025, driven by inpatient care, surgical planning, and emergency cases. But diagnostic imaging centers are growing at a faster rate, especially in North America and Asia. More than 45,000 independent centers operate across the globe, relieving outpatient demand and easing pressure on hospitals. Their quicker service turnaround time and cost-effectiveness make them a desirable option for patients who are in need of specialized imaging services.

By Distribution Channel, Direct Sales Lead While Online Retail Rises Quickly:

Direct sales remain the leading distribution route as major hospitals and health systems procure imaging systems directly from manufacturers, ensuring tailored service contracts and long-term support. But online retailing channels are growing especially for portable ultrasound and handheld devices. Over 20% of handheld ultrasound devices were sold online by 2025. Ease of access through internet-based purchase is opening up the technology to smaller clinics and research centers, while service models which are pay-as-you-go model are speeding up uptake.

Diagnostic Imaging Market Regional Analysis:

North America Diagnostic Imaging Market Insights:

North America dominates the global diagnostic imaging market with a 38.72% share in 2025E, driven by advanced healthcare infrastructure and strong reimbursement frameworks. The United States alone performs more than 80 million CT and MRI scans annually, using over 6,000 accredited imaging centers. Early adoption of AI-based imaging, dynamic government support and the existence of leading MedTech companies drive innovation, thereby promoting sustainable growth and technology leadership within the region.

U.S. Diagnostic Imaging Market Insights:

U.S. is imaging innovation leader with 6000+ accredited diagnostic centers and over 80 million CT and MRI techniques per year. The U.S. projected to have over 300 FDA cleared imaging devices by 2025, such as AI-enabled CT, hybrid PET-MRI and handheld ultrasound, will further consolidate the nation to be at center for state-of-the-art diagnostic technology.

Asia-Pacific Diagnostic Imaging Market Insights:

The Asia-Pacific diagnostic imaging market is projected to expand at a CAGR of 5.34%, making it the fastest-growing region globally. The area will of more than 120 million CT and MRI scans by 2025 as healthcare expenditure grows and urbanisation continues apace. China and India are demanding low-cost imaging access, whereas Japan and South Korea are adopting advanced modalities. In addition, increasing AI adoption and demand for portable imaging continue to drive market growth.

China Diagnostic Imaging Market Insights:

China serves as the largest Asia-Pacific diagnostic imaging industry, conducting more than 50 million CT scans per year and contributing up to almost a third of regional income. With over 40,000 hospitals and clinics providing imaging services, expansion is fuelled via government spending as part of the “Healthy China 2030” project and increasing penetration of hi-tech MRI & PET-CT technologies.

Europe Diagnostic Imaging Market Insights:

Europe is a central hub for diagnostic imaging, performing more than 100 million radiology examinations annually across Germany, France, the UK, and Italy. MRI penetration in the EU is also one of the highest internationally; the EU average lies at 120 MRI scanners per million population. Tax-payer funded; Imaging access is available to over 90% of population; High reinmbursement. With no fewer than 7,500 accredited imaging centers) and EUR funded R&D projects Europe is in the driving seat for hybrid solutions and AI-driven diagnostics.

Germany Diagnostic Imaging Market Insights:

The German market is Europe's largest and every year more than 25 million CT and MRI scans are carried out in Germany's 1,800 plus hospitals with imaging capabilities. Wide MRI usage (35 scanners per million people on average) and full public insurance uptake spur demand, aided by generous government investment in radiology research.

Latin America Diagnostic Imaging Market Insights:

The Latin American diagnostic imaging market is growing at a sustainable rate, with more than 45 million diagnostic imaging procedures carried out annually in Brazil, Mexico and Argentina. Brazil dominates with 60% of regional revenue sustained from over 3,500 diagnostic centers. Increasing Government Spending, Lower Cost and Increasing Number of Private Hospitals to Accelerate MRI And CT Adoption Among Urban Population.

Middle East and Africa Diagnostic Imaging Market Insights:

The Middle East & Africa diagnostic imaging market is expanding, with over 20 million imaging procedures a year expected by 2025. Saudi Arabia is the leading adopter with some 1,200+ hospitals fitted out with an imaging system, and South Africa accelerates as private healthcare expands. A growing incidence of non-communicable diseases, urbanisation and government spending are fuelling demand for CT and MRI scans.

Diagnostic Imaging Market Competitive Landscape:

Siemens Healthineers dominates diagnostic imaging with over 240,000 imaging systems installed worldwide across MRI, CT, and X-ray. Its AI-Rad Companion is installed in 5,000+ hospitals for automated image analysis to assist in first read detection and segmentation. With 19,000 patents and presence in over 70 countries, Siemens is the undisputed innovation leader in hybrid PET-CT and advanced MRI - A trusted partner for premium and high-volume healthcare providers alike.

  • In Sept 2025, installed the first U.S. Naeotom Alpha.Pro photon-counting CT at University Hospitals, Cleveland.

GE Healthcare has a strong presence with more than 1 million imaging devices installed globally, including leadership in CT and ultrasound. Its Edison AI platform fuels 50+ FDA cleared applications that are used in every day diagnostics. Working with more than 100 academic institutions across the globe, GE is advancing precision health through its handheld ultrasound systems, currently used in over 100 countries and serving as an essential tool in many developing and rural areas.

  • In July 2025, received FDA clearance for Aurora dual-head SPECT/CT and Clarify DL AI-powered image reconstruction.

Philips Healthcare stands out with 7,000+ high-field MRI systems installed worldwide, emphasizing strong capabilities in neuro and cardiac imaging. Its IntelliSpace AI workflow solutions run in over 2,500 hospitals driving efficiency and reducing scan times. With a presence in more than 120 countries, Philips is leading modern imaging development by connecting sustainable planning, digital platforms and AI to become the world’s leader in patient-centered technology for pathology diagnosis and precision radiology.

  • In March 2025, launched AI-enabled imaging systems and cloud services at ECR 2025 to enhance radiology workflows.

Diagnostic Imaging Market Key Players:

Some of the Diagnostic Imaging Market Companies are: 

  • Siemens Healthineers

  • GE Healthcare

  • Philips Healthcare

  • Canon Medical Systems

  • FUJIFILM Holdings

  • Hitachi Ltd.

  • Carestream Health

  • Agfa-Gevaert

  • Hologic, Inc.

  • Samsung Medison

  • Shimadzu Corporation

  • Mindray Medical International

  • Esaote S.p.A.

  • Konica Minolta, Inc.

  • CurveBeam LLC

  • United Imaging (China)

  • Allengers Medical Systems

  • Neusoft Medical Systems

  • Bracco S.p.A.

  • Varian Medical Systems

 

Diagnostic Imaging Market Report Scope:

Report Attributes Details
Market Size in 2025 USD 48.97 Billion 
Market Size by 2033 USD 68.11 Billion 
CAGR CAGR of 4.23% From 2026 to 2033
Base Year 2025
Forecast Period 2026-2033
Historical Data 2022-2024
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product Type (X-ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems (PET, SPECT), Mammography Systems, Others)
• By Application (Cardiology, Oncology, Neurology, Orthopedics, Gynecology, Gastroenterology, Others)
• By Technology (2D Imaging, 3D/4D Imaging, Fusion Imaging, Portable/Handheld Imaging Systems)
• By Modality (Fixed Imaging Systems, Portable Imaging Systems, Hybrid Imaging Systems)
• By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research & Academic Institutes, Others)
• By Distribution Channel (Direct Sales, Distributors, Online Retail, Others)
Regional Analysis/Coverage North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).
Company Profiles Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, FUJIFILM Holdings, Hitachi Ltd., Carestream Health, Agfa-Gevaert, Hologic, Inc., Samsung Medison, Shimadzu Corporation, Mindray Medical International, Esaote S.p.A., Konica Minolta, Inc., CurveBeam LLC, United Imaging (China), Allengers Medical Systems, Neusoft Medical Systems, Bracco S.p.A., Varian Medical Systems.

Table Of Contents

1. Introduction

1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2033

 2.3 Market Size & Forecast, By Segmentation, 2022–2033

  2.3.1 Market Size By Product Type

  2.3.2 Market Size By Application

  2.3.3 Market Size By Technology

  2.3.4 Market Size By Modality

  2.3.5 Market Size By End User

  2.3.6 Market Size By Distribution Channel

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw End User Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Procedure Volumes & Utilization

4.1.1 Annual global imaging procedures performed (% growth YoY)

4.1.2 Breakdown of procedure volumes by modality (CT %, MRI %, ultrasound %, X-ray %, PET %)

4.1.3 Average imaging procedures per 1,000 population (global %, regional %)

4.1.4 Growth in preventive screening exams (oncology %, cardiology %, neurology %)

     4.2 Infrastructure & Availability

4.2.1 Total number of diagnostic imaging devices installed globally (CT %, MRI %, ultrasound %, X-ray %)

4.2.2 Imaging units per million population (developed regions %, developing regions %)

4.2.3 Diagnostic imaging centers and hospitals equipped with advanced systems (%)

     4.3 Technology Adoption

4.3.1 Newly installed imaging systems integrated with AI each year (%)

4.3.2 Growth rate of digital and cloud-based imaging platforms (%)

4.3.3 Adoption levels of hybrid imaging systems (PET-CT %, PET-MRI %)

4.3.4 Share of portable and handheld imaging devices in total installations (%)

     4.4 Workforce & Operations

4.4.1 Global radiologists vs. demand gap (%) and regional shortages (%)

4.4.2 Average reporting turnaround time reduction with AI integration (%)

4.4.3 Radiology workload increase per radiologist annually (%)

5. Diagnostic Imaging Market Segmental Analysis & Forecast, By Product Type, 2022 – 2033, Value (USD Billion)

5.1 Introduction

 5.2 X-ray Systems

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2033

 5.3 Ultrasound Systems

    5.4 Computed Tomography (CT) Scanners

    5.5 Magnetic Resonance Imaging (MRI) Systems

    5.6 Nuclear Imaging Systems (PET, SPECT)

    5.7 Mammography Systems

    5.8 Others

6. Diagnostic Imaging Market Segmental Analysis & Forecast, By Application, 2022 – 2033, Value (USD Billion)

    6.1 Introduction

 6.2 Cardiology

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2033

 6.3 Oncology

     6.4 Neurology

     6.5 Orthopedics

     6.6 Gynecology

     6.7 Gastroenterology

     6.5 Others

7. Diagnostic Imaging Market Segmental Analysis & Forecast, By Technology, 2022 – 2033, Value (USD Billion)

    7.1 Introduction

 7.2 2D Imaging

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2033

 7.3 3D/4D Imaging

     7.4 Fusion Imaging

     7.5 Portable/Handheld Imaging Systems

8. Diagnostic Imaging Market Segmental Analysis & Forecast, By Modality, 2022 – 2033, Value (USD Billion)

    8.1 Introduction

 8.2 Fixed Imaging Systems

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2033

 8.3 Portable Imaging Systems

 8.4 Hybrid Imaging Systems

9. Diagnostic Imaging Market Segmental Analysis & Forecast, By End User, 2022 – 2033, Value (USD Billion)

    9.1 Introduction 

  9.2 Hospitals

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022 – 2033 

  9.3 Diagnostic Imaging Centers

  9.4 Ambulatory Surgical Centers

         9.5 Research & Academic Institutes

         9.6 Others

10. Diagnostic Imaging Market Segmental Analysis & Forecast, By Distribution Channel, 2022 – 2033, Value (USD Billion)

 10.1 Introduction

 10.2 Direct Sales

  10.2.1 Key Trends

  10.2.2 Market Size & Forecast, 2022 – 2033

 10.3 Distributors

 10.4 Online Retail

     10.5 Others

11. Diagnostic Imaging Market Segmental Analysis & Forecast By Region, 2022 – 2033, Value (USD Billion)

11.1 Introduction

 11.2 North America

  11.2.1 Key Trends

  11.2.2 Diagnostic Imaging Market Size & Forecast, By Product Type, 2022 – 2033

  11.2.3 Diagnostic Imaging Market Size & Forecast, By Application, 2022 – 2033

  11.2.4 Diagnostic Imaging Market Size & Forecast, By Technology, 2022 – 2033

  11.2.5 Diagnostic Imaging Market Size & Forecast, By Modality, 2022 – 2033

  11.2.6 Diagnostic Imaging Market Size & Forecast, By End User, 2022 – 2033

  11.2.7 Diagnostic Imaging Market Size & Forecast, By Distribution Channel, 2022 – 2033

  11.2.8 Diagnostic Imaging Market Size & Forecast, By Country, 2022 – 2033

   11.2.8.1 USA

   11.2.8.2 Canada

11.3 Europe

 11.3.1 Key Trends

 11.3.2 Diagnostic Imaging Market Size & Forecast, By Product Type, 2022 – 2033

 11.3.3 Diagnostic Imaging Market Size & Forecast, By Application, 2022 – 2033

 11.3.4 Diagnostic Imaging Market Size & Forecast, By Technology, 2022 – 2033

 11.3.5 Diagnostic Imaging Market Size & Forecast, By Modality, 2022 – 2033

 11.3.6 Diagnostic Imaging Market Size & Forecast, By End User, 2022 – 2033

 11.3.7 Diagnostic Imaging Market Size & Forecast, By Distribution Channel, 2022 – 2033

 11.3.8 Diagnostic Imaging Market Size & Forecast, By Country, 2022 – 2033

  11.3.8.1 Germany

  11.3.8.2 UK

  11.3.8.3 France

  11.3.8.4 Italy

  11.3.8.5 Spain

  11.3.8.6 Russia

  11.3.8.7 Poland

  11.3.8.8 Rest of Europe

11.4 Asia-Pacific

 11.4.1 Key Trends

 11.4.2 Diagnostic Imaging Market Size & Forecast, By Product Type, 2022 – 2033

 11.4.3 Diagnostic Imaging Market Size & Forecast, By Application, 2022 – 2033

 11.4.4 Diagnostic Imaging Market Size & Forecast, By Technology, 2022 – 2033

 11.4.5 Diagnostic Imaging Market Size & Forecast, By Modality, 2022 – 2033

 11.4.6 Diagnostic Imaging Market Size & Forecast, By End User, 2022 – 2033

 11.4.7 Diagnostic Imaging Market Size & Forecast, By Distribution Channel, 2022 – 2033

 11.4.8 Diagnostic Imaging Market Size & Forecast, By Country, 2022 – 2033

  11.4.8.1 China

  11.4.8.2 India

  11.4.8.3 Japan

  11.4.8.4 South Korea

  11.4.8.5 Australia

  11.4.8.6 ASEAN Countries

  11.4.8.7 Rest of Asia-Pacific

11.5 Latin America

 11.5.1 Key Trends

 11.5.2 Diagnostic Imaging Market Size & Forecast, By Product Type, 2022 – 2033

 11.5.3 Diagnostic Imaging Market Size & Forecast, By Application, 2022 – 2033

 11.5.4 Diagnostic Imaging Market Size & Forecast, By Technology, 2022 – 2033

 11.5.5 Diagnostic Imaging Market Size & Forecast, By Modality, 2022 – 2033

 11.5.6 Diagnostic Imaging Market Size & Forecast, By End User, 2022 – 2033

 11.5.7 Diagnostic Imaging Market Size & Forecast, By Distribution Channel, 2022 – 2033

 11.5.8 Diagnostic Imaging Market Size & Forecast, By Country, 2022 – 2033

  11.5.8.1 Brazil

  11.5.8.2 Argentina

  11.5.8.3 Mexico

  11.5.8.4 Colombia

  11.5.8.5 Rest of Latin America

11.6 Middle East & Africa

 11.6.1 Key Trends

 11.6.2 Diagnostic Imaging Market Size & Forecast, By Product Type, 2022 – 2033

 11.6.3 Diagnostic Imaging Market Size & Forecast, By Application, 2022 – 2033

 11.6.4 Diagnostic Imaging Market Size & Forecast, By Technology, 2022 – 2033

 11.6.5 Diagnostic Imaging Market Size & Forecast, By Modality, 2022 – 2033

 11.6.6 Diagnostic Imaging Market Size & Forecast, By End User, 2022 – 2033

 11.6.7 Diagnostic Imaging Market Size & Forecast, By Distribution Channel, 2022 – 2033

 11.6.8 Diagnostic Imaging Market Size & Forecast, By Country, 2022 – 2033

  11.6.8.1 UAE

  11.6.8.2 Saudi Arabia

  11.6.8.3 Qatar

  11.6.8.4 Egypt

  11.6.8.5 South Africa

  11.6.8.6 Rest of Middle East & Africa

12. Competitive Landscape

 12.1 Key Players' Positioning

 12.2 Competitive Developments

  12.2.1 Key Strategies Adopted (%), By Key Players, 2025

  12.2.2 Year-Wise Strategies & Development, 2022 – 2026

  12.2.3 Number Of Strategies Adopted By Key Players, 2025

 12.3 Market Share Analysis, 2025

 12.4 Product Type/Service & End User Benchmarking

  12.4.1 Product Type/Service Specifications & Features By Key Players

  12.4.2 Product Type/Service Heatmap By Key Players

  12.4.3 End User Heatmap By Key Players

 12.5 Industry Start-Up & Innovation Landscape

12.6 Key Company Profiles

 12.6.1 Siemens Healthineers

  12.6.1.1 Company Overview & Snapshot

  12.6.1.2 Product Type/Service Portfolio

  12.6.1.3 Key Company Financials

  12.6.1.4 SWOT Analysis

 12.6.2 GE Healthcare

12.6.3 Philips Healthcare

12.6.4 Canon Medical Systems

 12.6.5 FUJIFILM Holdings

 12.6.6 Hitachi Ltd.

 12.6.7 Carestream Health

 12.6.8 Agfa-Gevaert

12.6.9 Hologic, Inc.

12.6.10 Samsung Medison

 12.6.11 Shimadzu Corporation

 12.6.12 Mindray Medical International

 12.6.13 Esaote S.p.A.

 12.6.14 Konica Minolta, Inc.

 12.6.15 CurveBeam LLC

 12.6.16 United Imaging (China)

 12.6.17 Allengers Medical Systems

 12.6.18 Neusoft Medical Systems

 12.6.19 Bracco S.p.A.

 12.6.20 Varian Medical Systems

13. Analyst Recommendations

 13.1 SNS Insider Opportunity Map

 13.2 Industry Low-Hanging Fruit Assessment

 13.3 Market Entry & Growth Strategy

 13.4 Analyst Viewpoint & Suggestions On Market Growth

14. Assumptions

15. Disclaimer

16. Appendix

 16.1 List Of Tables

 16.2 List Of Figures

Key Segmentation

By Product Type

  • X-ray Systems

  • Ultrasound Systems

  • Computed Tomography (CT) Scanners

  • Magnetic Resonance Imaging (MRI) Systems

  • Nuclear Imaging Systems (PET, SPECT)

  • Mammography Systems

  • Others

By Application

  • Cardiology

  • Oncology

  • Neurology

  • Orthopedics

  • Gynecology

  • Gastroenterology

  • Others

By Technology

  • 2D Imaging

  • 3D/4D Imaging

  • Fusion Imaging

  • Portable/Handheld Imaging Systems

By Modality

  • Fixed Imaging Systems

  • Portable Imaging Systems

  • Hybrid Imaging Systems

By End User

  • Hospitals

  • Diagnostic Imaging Centers

  • Ambulatory Surgical Centers

  • Research & Academic Institutes

  • Others

By Distribution Channel

  • Direct Sales

  • Distributors

  • Online Retail

  • Others

Request for Segment Customization as per your Business Requirement: 

Segment Customization Request

Regional Coverage: 

North America

  • US

  • Canada

Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Russia

  • Poland

  • Rest of Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • ASEAN Countries

  • Rest of Asia Pacific

Middle East & Africa

  • UAE

  • Saudi Arabia

  • Qatar

  • South Africa

  • Rest of Middle East & Africa

Latin America

  • Brazil

  • Argentina

  • Mexico

  • Colombia

  • Rest of Latin America

Request for Country Level Research Report: Country Level Customization Request

Available Customization 

With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report: 

  • Detailed Volume Analysis 

  • Criss-Cross segment analysis (e.g. Product X Application) 

  • Competitive Product Benchmarking 

  • Geographic Analysis 

  • Additional countries in any of the regions 

  • Customized Data Representation 

  • Detailed analysis and profiling of additional market player

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.